SEATTLE and VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and ...
In front of a sea of swaying congregants, Cindy Jacobs ascended the expansive stage holding a microphone. A band of about ten musicians had just wrapped up a 45-minute set of praise and worship music ...
Jacobs highlighted Achieve’s redevelopment of this drug into a novel treatment for nicotine addiction, now known as cytisinicline. This new cytisinicline product features a revised formulation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback